Advertisement

Topics

MeiraGTx Company Profile

19:05 EDT 21st October 2018 | BioPortfolio

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers, as well as certain neurodegenerative diseases. In addition, MeiraGTx is developing novel gene regulation platforms that it believes will transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.


News Articles [29 Associated News Articles listed on BioPortfolio]

MeiraGTx Files for an $86 Million IPO

MeiraGTx has filed with the U.S. Securities and Exchange Commission (SEC) its intentions to launch an initial public offering (IPO).

FDA orphan status given to MeiraGTx's colorblindness therapy

MeiraGTx's AAV-CNGA3, which is being developed for the treatment of achromatopsia caused by mutations in the CNGA3 gene, rece -More- 

Gene Therapy Company MeiraGTx Buys Vector Neurosciences for Its Phase II Parkinson's Product

MeiraGTx, headquartered in London, UK, acquired Vector Neurosciences in an all-stock deal. As part of the deal, MeiraGTx picks up Vector’s Phase II gene therapy program for Parkinson’s disease.

MeiraGTx, Janssen Enter Research Collaboration

MeiraGTx will use their riboswitch technology to engineer gene therapy constructs encoding gene sequences from Janssen

Gene therapy start-up MeiraGTx nets $80.2mm in Nasdaq IPO

In its initial public offering on the Nasdaq Exchange, MeiraGTx Holdings PLC (developing AAV gene therapies) netted $80.2mm through the sale of 5.75mm shares (including the overallotment) at $15, the ...

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company...

FDA gives rare pediatric disease status to MeiraGTx's achromatopsia drug

MeiraGTx's AAV-CNGA3, being developed to treat patients with achromatopsia due to mutations in the CNGA3 gene, was given rare -More- 

MeiraGTx acquires AAV gene therapy company Vector Neurosciences for up to $24mm

MeiraGTx Holdings PLC acquired privately held fellow gene therapy biotech Vector Neurosciences Inc. in an all-stock transaction, issuing a total of 225k Class A ordinary shares (valued at $3mm) to Vec...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

MeiraGTx

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing pote...

MeiraGTx Limited

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing pote...

More Information about "MeiraGTx" on BioPortfolio

We have published hundreds of MeiraGTx news stories on BioPortfolio along with dozens of MeiraGTx Clinical Trials and PubMed Articles about MeiraGTx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MeiraGTx Companies in our database. You can also find out about relevant MeiraGTx Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record